TDI-01

N/A

Report date: 2026/03/12 20:00:16
NME

Base Information

Drug NameTDI-01
Drug Alias NameTDI01TDI-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 2
Therapy Area/IndicationsFibrosisGraft vs Host DiseaseRenal Insufficiency, Chronic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Tide Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGraviton Bioscience CorpBeijing Tide Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsFibrosisGraft vs Host DiseaseRenal Insufficiency, Chronic +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A